top of page

About Us
Amytrx is a clinical-stage biopharmaceutical company advancing the next generation of new anti-inflammatory peptide therapies for patients suffering from chronic inflammatory diseases. We are a group of dedicated scientific, medical, and business professionals all deeply committed to positively transforming the health and lives of patients.
Leadership Team
.png)
Matthew A. Gonda, Ph.D.
President, CEO and Founder
.jpg)
Randall B. Riggs, MBA
Chief Business Officer
.jpg)
Shima Joshi, Ph.D.
VP, CMC and Regulatory Affairs
.jpg)
Vernon L. Alvarez, Ph.D.
SVP, Research & Development
.jpg)
Satish Joshi, Ph.D.
VP, Peptide Chemistry
Board of Directors
Matthew A. Gonda, Ph.D.
President, CEO and Founder
Michael Howell, Ph.D.
Director
Satish Joshi, Ph.D.
Director
Lawrence W. Greer, DDS, MBA
Director
Raymond Pirtle, Jr.
Director
Dennis J. Carlo, Ph.D.
Director
bottom of page